As mentioned above, the studys results showed enhanced blood flow to sexual organs
Dont forget to add a healthy diet to the pile
In August 2025, Novo Nordisk announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding cirrhosis, in combination with diet and exercise
S1, May 2023, p
These changes can be implemented immediately and can be an easy fix to potentially prevent these side effects. ### About AAOS With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the worlds largest medical association of musculoskeletal specialists
The way consumers react to these products is going to change with the new drugs coming on the market, explained Jennifer Kimmel, head of R&D, Roquette Americas